A stable gastric cancer cell line knocking down TRIP13 using lentiviral interference technology (Fig. 2A) was developed to explore the effect of TRIP13 on the proliferation ability of gastric cancer cells. The gene discussed is TRIP13; the disease is gastric cancer.